BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 19800137)

  • 1. The U937 macrophage cell line expresses enzymatically active L-Dopa decarboxylase.
    Kokkinou I; Fragoulis EG; Vassilacopoulou D
    J Neuroimmunol; 2009 Nov; 216(1-2):51-8. PubMed ID: 19800137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of enzymatically active L-DOPA decarboxylase in human peripheral leukocytes.
    Kokkinou I; Nikolouzou E; Hatzimanolis A; Fragoulis EG; Vassilacopoulou D
    Blood Cells Mol Dis; 2009; 42(1):92-8. PubMed ID: 19041269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning and expression of human placental L-Dopa decarboxylase.
    Siaterli MZ; Vassilacopoulou D; Fragoulis EG
    Neurochem Res; 2003 Jun; 28(6):797-803. PubMed ID: 12718431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression analysis and clinical utility of L-Dopa decarboxylase (DDC) in prostate cancer.
    Avgeris M; Koutalellis G; Fragoulis EG; Scorilas A
    Clin Biochem; 2008 Oct; 41(14-15):1140-9. PubMed ID: 18586020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression changes induced by bismuth in a macrophage cell line.
    Magnusson NE; Larsen A; Rungby J; Kruhøffer M; Orntoft TF; Stoltenberg M
    Cell Tissue Res; 2005 Aug; 321(2):195-210. PubMed ID: 15912405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopa decarboxylase: a model gene-enzyme system for studying development, behavior, and systematics.
    Hodgetts RB; O'Keefe SL
    Annu Rev Entomol; 2006; 51():259-84. PubMed ID: 16332212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for L-Dopa Decarboxylase Involvement in Cancer Cell Cytotoxicity Induced by Docetaxel and Mitoxantrone.
    Kalantzis ED; Scorilas A; Vassilacopoulou D
    Curr Pharm Biotechnol; 2018; 19(13):1087-1096. PubMed ID: 30417785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and identification of L-dopa decarboxylase as a protein that binds to and enhances transcriptional activity of the androgen receptor using the repressed transactivator yeast two-hybrid system.
    Wafa LA; Cheng H; Rao MA; Nelson CC; Cox M; Hirst M; Sadowski I; Rennie PS
    Biochem J; 2003 Oct; 375(Pt 2):373-83. PubMed ID: 12864730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.
    Chartoff EH; Szczypka MS; Palmiter RD; Dorsa DM
    Brain Res; 2004 Oct; 1022(1-2):71-80. PubMed ID: 15353215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural insight into Parkinson's disease treatment from drug-inhibited DOPA decarboxylase.
    Burkhard P; Dominici P; Borri-Voltattorni C; Jansonius JN; Malashkevich VN
    Nat Struct Biol; 2001 Nov; 8(11):963-7. PubMed ID: 11685243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human L-DOPA decarboxylase mRNA is a target of miR-145: A prediction to validation workflow.
    Papadopoulos EI; Fragoulis EG; Scorilas A
    Gene; 2015 Jan; 554(2):174-80. PubMed ID: 25445287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo regulation of DOPA decarboxylase by dopamine receptors in rat brain.
    Cumming P; Ase A; Laliberté C; Kuwabara H; Gjedde A
    J Cereb Blood Flow Metab; 1997 Nov; 17(11):1254-60. PubMed ID: 9390657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetics of dopa decarboxylase and biogenic amines in Drosophila.
    Hirsh J
    Dev Genet; 1989; 10(3):232-8. PubMed ID: 2500287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the dopa decarboxylase gene of Manduca sexta and its suppression by 20-hydroxyecdysone.
    Hiruma K; Carter MS; Riddiford LM
    Dev Biol; 1995 May; 169(1):195-209. PubMed ID: 7750638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene activation mediated by protein kinase C in human macrophage and teratocarcinoma cells expressing aminoglycoside phosphotransferase activity.
    Maio JJ; Brown FL
    J Cell Physiol; 1991 Dec; 149(3):548-59. PubMed ID: 1660486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The coordination of the sequential appearance of MHR4 and dopa decarboxylase during the decline of the ecdysteroid titer at the end of the molt.
    Hiruma K; Riddiford LM
    Mol Cell Endocrinol; 2007 Sep; 276(1-2):71-9. PubMed ID: 17706862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of functional dopaminergic phenotype in purified cultured Müller cells from vertebrate retina.
    Kubrusly RC; Panizzutti R; Gardino PF; Stutz B; Reis RA; Ventura AL; de Mello MC; de Mello FG
    Neurochem Int; 2008 Sep; 53(3-4):63-70. PubMed ID: 18582514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of a human DOPA decarboxylase cDNA probe by PCR and its assignment to chromosome 7.
    Bruneau G; Gross MS; Krieger M; Bernheim A; Thibault J; Nguyen VC
    Ann Genet; 1990; 33(4):208-13. PubMed ID: 1710430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual beta-adrenergic modulation in the immune system: stimulus-dependent effect of isoproterenol on MAPK activation and inflammatory mediator production in macrophages.
    Szelenyi J; Selmeczy Z; Brozik A; Medgyesi D; Magocsi M
    Neurochem Int; 2006 Jul; 49(1):94-103. PubMed ID: 16515823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Midkine is a potent regulator of the catecholamine biosynthesis pathway in mouse aorta.
    Ezquerra L; Herradon G; Nguyen T; Silos-Santiago I; Deuel TF
    Life Sci; 2006 Aug; 79(11):1049-55. PubMed ID: 16643958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.